Is the apparent efficacy of treatments being altered by bias? A recent study takes a closer look at the cumulative effects of reporting and citation biases.
eLife is trialling a novel form of open peer review that gives authors more control over their response to reviewers.
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
Learn more about the potential impact of cOAlition S: a commitment to make all European publicly funded research freely available by 2020.
Get up to speed with the latest tips for increasing patient involvement in publications from Elevate Magazine.
In a recent publication, researchers examine whether funder open access platforms are a good idea.
Robert-Jan Smits, a senior European Commission official comments on whether open access for all scientific papers by 2020 is a realistic goal.
The Publication Plan remembers Professor Doug Altman, founder of the EQUATOR network, who passed away last month.
CBI’s Publication Planning Meeting is back by popular demand with new dates and an exciting new programme.
In a recent MAP newsletter, ISMPP share an update from ASCO on their new open access option for industry-funded research.
Mary Yianni, Publisher at Taylor and Francis, reviews the different models of peer review and the emerging role of preprints.
Don’t forget! From 1 July 2018, ICMJE requires all reports of clinical trial data to include a data sharing statement.
How can journals, institutions, funders and societies improve and standardise the current authorship system?
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Missed the 14th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.